In another clinical trial that assessed a cohort with prediabetes and overweight/obesity, fasting plasma LEAP2 levels were inversely associated with insulin sensitivity and positively associated with BMI, body weight, and fat mass [42]. This evidence concerns the gene LEAP2 and obesity due to melanocortin 4 receptor deficiency.